Format

Send to

Choose Destination
Can J Public Health. 2018 Apr;109(2):227-230. doi: 10.17269/s41997-018-0089-7. Epub 2018 May 9.

Expanding supervised injection facilities across Canada: lessons from the Vancouver experience.

Author information

1
Department of Medicine, University of British Columbia, 2775 Laurel Street, 10th Floor, Vancouver, British Columbia, V5Z 1M9, Canada.
2
British Columbia Centre on Substance Use, British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 608-1081 Burrard St, Vancouver, British Columbia, V6Z 1Y6, Canada. nfairbairn@cfenet.ubc.ca.
3
Division of AIDS, Department of Medicine, University of British Columbia, 667-1081 Burrard St, Vancouver, British Columbia, V6Z 1Y6, Canada. nfairbairn@cfenet.ubc.ca.

Abstract

The opioid crisis has led to an unprecedented rise in the number of overdose deaths across Canada. In response, there has been an expansion of supervised injection facilities (SIFs), with several new SIFs approved or under review across the country. Much of the evidence for the benefits of SIFs in reducing overdose mortality, infectious-related complications, and public disorder comes from Insite in Vancouver, North America's first SIF. While implementing SIFs in other Canadian cities is a major step forward in combating the opioid epidemic, the diversity within our country's socio-demographic and political landscape leaves the application of SIFs in these new settings a matter of uncertainty. This commentary highlights key lessons learned from Vancouver and the potential modifications required to enhance implementation in other cities to ensure the success of new SIFs across Canada.

KEYWORDS:

Drug overdose; Harm reduction; Intravenous injections

PMID:
29981039
DOI:
10.17269/s41997-018-0089-7

Supplemental Content

Loading ...
Support Center